Pharming announces completion of its refinancing with a single US$100 million debt facility on improved commercial terms

Repayment of bridge finance on unchanged terms Leiden, The Netherlands, 21 July 2017: Pharming Group N.V. (“Pharming” or “the Company”) [...]

Pharming Reports On Annual General Meeting Of Shareholders

Leiden, The Netherlands, 24 May 2017, Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) announces that at its [...]


27jul07:00- 09:001H Results